Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498342 · ClinicalTrials.gov registry record · NA
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
A NA study of Chronic Kidney Disease, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00498342: Completed NA study of Chronic Kidney Disease, sponsored by University of Vermont.
NCT00498342 is a NA study of Chronic Kidney Disease that has completed, run by University of Vermont. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498342, a NA study of Chronic Kidney Disease, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
Primary outcome: Serum creatinine change at 4 hours and 48 hours following 4 doses of N-acetylcysteine (total 4800 mg) compared to baseline serum creatinine. Secondary outcome: Serum Cystatin C change at 4 hours and 48 hours post 4 doses of N-acetylcysteine compared to baseline serum Cystatin C.
Conditions Studied
Interventions
- DRUG N-acetylcysteine
Study Locations (1)
Vermont
- University of Vermont /Fletcher Allen Health Care, Inc. - Burlington
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-06 |
| Est. Completion | 2008-02 |
| Phase | NA |
What the finished NCT00498342 record still lists
NCT00498342 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which N-acetylcysteine is the first listed.
NCT00498342 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT00498342 about?
NCT00498342 is a clinical study titled "The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease". Primary outcome: Serum creatinine change at 4 hours and 48 hours following 4 doses of N-acetylcysteine (total 4800 mg) compared to baseline serum creatinine. Secondary outcome: Serum Cystatin C change at 4 hours and 48 hours post 4 doses of N-acetylcysteine compared to baseline serum Cystatin C.
What is the current status of trial NCT00498342?
This trial is currently completed. It is a NA study. The study started on 2007-06. Estimated completion is 2008-02.
What conditions does trial NCT00498342 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT00498342?
The interventions under investigation include: N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00498342?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00498342 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transforming Hemodialysis-Related Vascular Access Education
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia